Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatima Rizvi

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Journal of Personalized Medicine|July 27, 2024
The Role of Pro-Inflammatory Chemokines CCL-1, 2, 4, and 5 in the Etiopathogenesis of Type 2 Diabetes Mellitus in Subjects from the Asir Region of Saudi Arabia: Correlation with Different Degrees of ObesityMohammad Muzaffar Mir, Jaber Alfaifi, Shahzada Khalid Sohail, et al.
Journal of Comparative Effectiveness Research|March 12, 2026
A novel real-world data methodology for lymphoma outcome classification: the real-world Lugano studyRichard Scott Swain, Andrew Klink, Parisa Asgarisabet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2020
FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast CancerJennifer J Gao, Christy L Osgood, Yutao Gong, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Journal of Personalized Medicine|July 27, 2024
The Role of Pro-Inflammatory Chemokines CCL-1, 2, 4, and 5 in the Etiopathogenesis of Type 2 Diabetes Mellitus in Subjects from the Asir Region of Saudi Arabia: Correlation with Different Degrees of ObesityMohammad Muzaffar Mir, Jaber Alfaifi, Shahzada Khalid Sohail, et al.
Journal of Comparative Effectiveness Research|March 12, 2026
A novel real-world data methodology for lymphoma outcome classification: the real-world Lugano studyRichard Scott Swain, Andrew Klink, Parisa Asgarisabet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2020
FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast CancerJennifer J Gao, Christy L Osgood, Yutao Gong, et al.
Pageof 9